Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biden Turns To Cold War Measure To Expand Access to COVID-19 Tests

Executive Summary

President Biden outlined his pandemic strategy in a speech from the White House Thursday. The president invoked the Defense Production Act to quicken the availability of tests and issued a series of steps to increase vaccinations, including mandates.

You may also be interested in...



AdvaMed’s MedTech ’21: Focus On MCIT, MDUFA At Hybrid Meeting

Virtual and in-person events are planned for Washington, DC, and Minneapolis, MN, during the trade group gathering.

Virus Resurgence Means More Need For Tests

With COVID-19 infection rates on the rise again throughout much of the US, device manufacturers are trying to answer the need for more tests.

Congress Marks First Telehealth Awareness Week

US lawmakers issued a bipartisan resolution in recognition of the first Telehealth Awareness Week sponsored by the American Telemedicine Association. The resolution illustrates telehealth’s broad support and appeal.

Topics

UsernamePublicRestriction

Register

MT144447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel